Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone (Q39361359)

11 September 2017

Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone (English)

1 reference

11 September 2017

J Seifert

1

1 reference

11 September 2017

C Metzner

2

1 reference

11 September 2017

W Paetzold

3

1 reference

11 September 2017

M Borsutzky

4

1 reference

11 September 2017

M Ohlmeier

5

1 reference

11 September 2017

T Passie

6

1 reference

11 September 2017

U Hauser

7

1 reference

11 September 2017

H Becker

8

1 reference

11 September 2017

B Wiese

9

1 reference

11 September 2017

Hm Emrich

10

1 reference

11 September 2017

U Schneider

11

1 reference

11 September 2017

language of work or name

1 reference

1 June 2005

1 reference

11 September 2017

1 reference

11 September 2017

10

1 reference

11 September 2017

2

1 reference

11 September 2017

157-164

1 reference

Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor

11 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Methadone dose decreases and anxiety reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Drugs of abuse: anatomy, pharmacology and function of reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Buprenorphine detoxification from opioid dependence: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Treating opioid dependence. Growing implications for primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Buprenorphine has potent kappa opioid receptor antagonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Are detoxification programmes effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Double-blind randomized trial of buprenorphine and methadone in opiate dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

Role of maintenance treatment in opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210500123191

10.1080/13556210500123191

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference